Log In
BCIQ
Print this Print this
 

VOLT02

  Manage Alerts
Collapse Summary General Information
Company Levolta Pharmaceuticals Inc.
DescriptionConjugated progesterone
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationShock / trauma
Indication DetailsTreat traumatic brain injury (TBI)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today